Sign In
Buy LIFE
$16.89
-0.375 (-2.17%)
At Close: Jun 03, 2026
aTyr Pharma Announces Third Quarter 2020 Results and Provides Corporate Update
04:05pm, Thursday, 12'th Nov 2020
C omplete s e nrollment of ATYR1923 c linical t rial in patients with COVID-19 s evere r espiratory c omplications . Topline data is expected at turn of calendar year.
aTyr Pharma Announces Publication in the Journal mAbs
07:00am, Wednesday, 11'th Nov 2020
Peer-reviewed paper supports aTyr's antibody program .
aTyr Pharma to Participate in ROTH Capital Partners Webinar on COVID-19 Therapeutics in Development on October 28th
07:00am, Tuesday, 27'th Oct 2020
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological path
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
10:49am, Friday, 11'th Sep 2020
Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q2 2020 Results - Earnings Call Transcript
11:31pm, Thursday, 13'th Aug 2020
aTyr Pharma, Inc. (NASDAQ:LIFE) Q2 2020 Earnings Conference Call August 13, 2020 05:00 p.m.
Atyr Pharma (LIFE) Reports Q2 Loss, Misses Revenue Estimates
09:15pm, Thursday, 13'th Aug 2020
Atyr Pharma (LIFE) delivered earnings and revenue surprises of 5.48% and -52.75%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs
08:00pm, Thursday, 13'th Aug 2020
Company to host conference call and webcast today, August 13, at 5:00 p.m. EDT / 2:00 p.m. PDTSAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company e
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
11:00am, Tuesday, 11'th Aug 2020
Study will evaluate the safety, pharmacokinetics and immunogenicity of ATYR1923 in healthy volunteers in Japan.SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biothera
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2020 Financial Results
12:01pm, Thursday, 06'th Aug 2020
Management to host conference call and webcast on August 13th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engag
Atyr Pharma (LIFE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:30pm, Wednesday, 05'th Aug 2020
Atyr Pharma (LIFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Offer Insights on Healthcare Companies: Karuna Therapeutics (NASDAQ: KRTX) and aTyr Pharma (NASDAQ: LIFE) - Markets
10:21am, Wednesday, 24'th Jun 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Karuna Therapeutics (KRTX – Research
Edited Transcript of LIFE earnings conference call or presentation 12-May-20 9:00pm GMT
08:52pm, Monday, 22'nd Jun 2020
Q1 2020 aTyr Pharma Inc Earnings Call
SAN DIEGO, June 22, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathway
